Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

Peuchmaur M, d'Amore ES, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H.

Cancer. 2003 Nov 15;98(10):2274-81.

2.

Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.

Umehara S, Nakagawa A, Matthay KK, Lukens JN, Seeger RC, Stram DO, Gerbing RB, Shimada H.

Cancer. 2000 Sep 1;89(5):1150-61.

PMID:
10964346
3.

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK.

Cancer. 2001 Nov 1;92(9):2451-61.

PMID:
11745303
4.

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.

Cancer. 2001 Nov 15;92(10):2699-708.

PMID:
11745206
5.

The International Neuroblastoma Pathology Classification (the Shimada system).

Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, Stram DO, Gerbing RB, Lukens JN, Matthay KK, Castleberry RP.

Cancer. 1999 Jul 15;86(2):364-72.

PMID:
10421273
6.

[Peripheral neuroblastic tumors: anatomo pathological classification].

Peuchmaur M.

Ann Pathol. 2004 Dec;24(6):556-67. Review. French.

PMID:
15785402
7.

Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.

Navarro S, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Mosseri V, De Bernardi B, Michon J, Peuchmaur M; European Study Group 94.01 Trial and Protocol.

J Clin Oncol. 2006 Feb 1;24(4):695-9.

PMID:
16446343
8.

Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.

Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B.

Cancer. 1999 Jul 15;86(2):349-63.

PMID:
10421272
9.

TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.

Shimada H, Nakagawa A, Peters J, Wang H, Wakamatsu PK, Lukens JN, Matthay KK, Siegel SE, Seeger RC.

Cancer. 2004 Oct 15;101(8):1873-81.

10.

[Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].

YIN MZ, ZHANG ZD, MA J, SHEN P, CHEN JF, ZHANG HZ.

Zhonghua Bing Li Xue Za Zhi. 2011 Mar;40(3):151-5. Chinese.

PMID:
21575383
11.

International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.

Sano H, Bonadio J, Gerbing RB, London WB, Matthay KK, Lukens JN, Shimada H.

Eur J Cancer. 2006 May;42(8):1113-9. Epub 2006 Apr 18.

PMID:
16624549
12.

Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.

Ambros IM, Hata J, Joshi VV, Roald B, Dehner LP, Tüchler H, Pötschger U, Shimada H.

Cancer. 2002 Mar 1;94(5):1574-83.

13.

[Clinicopathologic features of peripheral neuroblastic tumors].

Yang BF, Fu LB, He LJ.

Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):305-10. doi: 10.3760/cma.j.issn.0529-5807.2013.05.004. Chinese.

PMID:
24004586
14.

Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.

Tornóczky T, Kálmán E, Kajtár PG, Nyári T, Pearson AD, Tweddle DA, Board J, Shimada H.

Cancer. 2004 Jan 15;100(2):390-7.

15.

Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.

Joshi VV, Cantor AB, Altshuler G, Cohen LJ, Larkin EW, Shuster JJ, Rao PV, Holbrook CT, Hayes FA, Castleberry RP.

Arch Pathol Lab Med. 1996 Sep;120(9):859-65.

PMID:
9140292
16.

Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H.

Pediatr Blood Cancer. 2009 Oct;53(4):563-9. doi: 10.1002/pbc.22106.

17.
18.

Tumors of the neuroblastoma group.

Shimada H.

Pathology (Phila). 1993;2(1):43-59. Review.

PMID:
9420930
19.

Neuroblastoma in adolescents: the Italian experience.

Conte M, Parodi S, De Bernardi B, Milanaccio C, Mazzocco K, Angelini P, Viscardi E, Di Cataldo A, Luksch R, Haupt R.

Cancer. 2006 Mar 15;106(6):1409-17.

20.

Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.

Angelini P, London WB, Cohn SL, Pearson AD, Matthay KK, Monclair T, Ambros PF, Shimada H, Leuschner I, Peuchmaur M, Irwin MS, Baruchel S.

Eur J Cancer. 2012 May;48(8):1185-91. doi: 10.1016/j.ejca.2011.10.037. Epub 2011 Dec 1.

PMID:
22137163

Supplemental Content

Support Center